DPP4 inhibitors and cardiovascular outcomes: safety on heart failure

@article{Xia2017DPP4IA,
  title={DPP4 inhibitors and cardiovascular outcomes: safety on heart failure},
  author={Chang Xia and Aditya Goud and Jason D'souza and Chanukya R Dahagam and Xiaoquan Rao and Sanjay Rajagopalan and Jixin Zhong},
  journal={Heart Failure Reviews},
  year={2017},
  volume={22},
  pages={299-304}
}
Diabetes is an important risk factor for cardiovascular disease. However, clinical data suggests intensive glycemic control significantly increase rather than decrease cardiovascular mortality, which is largely due to the fact that a majority of oral anti-diabetic drugs have adverse cardiovascular effect. There are several large-scale clinical trials… CONTINUE READING